REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Regeneron Pharmaceuticals (REGN) stock is on the rise Thursday after the company released its latest clinical trial data on Dupixent.

The post REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• It doesn’t matter if you have $500 or $5 million. Do this now.
• Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It